Rick Simpson Oil (RSO) in Winnebago County, Iowa: The Complete Guide by OilWell Cannabis

If you’re searching for Rick Simpson Oil in Winnebago County, Iowa, you’re likely looking for answers that conventional medicine hasn’t provided. Maybe you’re a cancer patient at MercyOne in Mason City, a farmer outside Forest City dealing with chronic pain from years of physical labor, a veteran in Lake Mills struggling with PTSD, or a caregiver in Thompson exploring options for a loved one with sleep disorders. We understand. At OilWell Cannabis, we’ve built our entire company around the principle that people deserve honest, evidence-based information about cannabinoids—not hype, not promises, but real science they can use to make informed decisions about their health.

This guide is for every resident of Winnebago County: from the agricultural communities in Buffalo Center to the families in Rake, from the healthcare workers at Hancock County Health System to the students at Waldorf University in Forest City. Whether you’re cannabis-curious and just beginning your research, or you’re an experienced user looking for the most advanced multi-cannabinoid formula available, you’ll find complete, transparent information here. We publish everything—our formulas, our sources, our evidence, even our recipe—because Bentley taught us that when lives depend on it, transparency isn’t optional.

Understanding Rick Simpson Oil: The Foundation

Who Was Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical professional—he was a power engineer and maintenance worker, a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering. In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications he was prescribed either failed to help or made his condition worse. When he found cannabis provided relief and asked his doctor to consider it, the request was refused.

Simpson’s interest in concentrated cannabis oil deepened after learning about a 1974 study funded by the National Institute of Health at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study—intended to demonstrate harm—became foundational to Simpson’s advocacy, even though its findings were never replicated in controlled human cancer trials.

The pivotal moment came in 2003. Simpson claimed three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursue conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification, biopsy confirmation, or clinical follow-up has ever been published in any peer-reviewed source. This personal experience became the origin story of Rick Simpson Oil.

Important context for Winnebago County readers: Simpson’s account is personal testimony, not medical evidence. It cannot be evaluated as clinical proof, but it is historically significant as the catalyst for a global movement. We present his story honestly because Winnebago County residents deserve the same transparency we apply to our own products.

The 60-Gram Protocol: What Simpson Recommended

Simpson’s core treatment protocol involved consuming 60 grams of concentrated cannabis oil over approximately 90 days. Here’s the complete breakdown:

Week 1: Begin with a dose the size of half a grain of rice—about 10-15mg—taken three times daily (morning, afternoon, before bed). Total daily intake: 30-45mg.

Weeks 2-5: Double the dose approximately every four days to build tolerance gradually. By week five, reach approximately 1 gram (1,000mg) of oil per day, divided into three doses of roughly 333mg each.

Weeks 5-12: Maintain 1 gram per day until all 60 grams are consumed.

Administration methods: Simpson recommended sublingual/oral as primary, topical for skin cancers, and acknowledged inhalation for immediate symptom relief but not as primary treatment.

Tolerance and psychoactive effects: Simpson maintained patients would develop tolerance to THC’s psychoactive effects within 3-4 weeks. He recommended nighttime dosing initially and warned against driving.

Post-protocol maintenance: After completing the 60-gram course, Simpson recommended 1-2 grams per month indefinitely.

Important safety context for Winnebago County: This protocol was designed around crude, unstandardized material with no controlled trial validation. At peak dosing, patients consumed approximately 600-900mg of delta-9 THC daily—a dose far exceeding anything studied clinically. These levels carry serious risks including severe intoxication, anxiety, tachycardia, hypotension, and cannabis use disorder. For cancer patients in Winnebago County considering this approach, we strongly recommend consulting with oncologists at MercyOne in Mason City or working with primary care providers at Hancock County Health System before making any treatment decisions.

What Traditional RSO Actually Was

Traditional RSO was defined by Simpson’s method, not lab specifications:

• Source material: Single high-THC indica strain, no standardization
• Extraction solvent: Naphtha (petroleum-based) or 99% isopropyl alcohol—neither food-grade
• Process: Bucket, solvent wash, filter, rice cooker evaporation, syringe storage
• Appearance: Nearly black, thick, tar-like oil with strong cannabis odor
• Cannabinoid profile: 60-90% delta-9 THC, no ratio control, unmeasured minor cannabinoids
• Terpene content: Minimal to none—destroyed by solvent and heat
• Standardization: None. Every batch varied based on starting material, growing conditions, and extraction technique
• Residual solvent risk: Significant. Naphtha may contain benzene, toluene, and other carcinogens

For Winnebago County residents who may have encountered DIY RSO makers or products at local markets, understanding these safety limitations is crucial.

Simpson’s Claims vs. The Evidence

Simpson claimed RSO could cure cancer, diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, and more. Here’s what the evidence actually shows:

What Simpson was not: He had no medical training, conducted no clinical trials, published no peer-reviewed research. His evidence base consisted entirely of personal experience and testimonials.

Preclinical literature: In vitro studies show THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal studies show some tumor-growth inhibition. These findings are scientifically interesting but have not translated to proven human cancer cures.

What the literature does NOT show: No human clinical trial has demonstrated RSO cures cancer. The gap between lab results and human outcomes is vast.

Institutional positions:

• National Cancer Institute acknowledges cannabinoid anticancer research but does not endorse cannabis as cancer treatment
• FDA has not approved any cannabis plant product for cancer
• Health Canada has never approved RSO for cancer
• NCCIH identifies strongest evidence for epilepsy, chemo nausea, and HIV/AIDS appetite—not cancer cure

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world was ignoring them. He helped create conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: Cure claims exceeded evidence. Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential. Delayed or foregone treatment is a documented concern in alternative medicine.

For Winnebago County cancer patients, we emphasize: RSO education complements medical care—it never replaces it. If you’re receiving treatment at MercyOne’s Cancer Center in Mason City or working with specialists in the region, any cannabinoid use should be discussed with your oncology team.

The OilWell Evolution: From Bentley to Winnebago County

Our Origin: A Dog Named Bentley

OilWell Cannabis didn’t begin in a boardroom—it began with a paralyzed dog named Bentley facing euthanasia. Colin Valencia’s companion was told by veterinarians that pain medications would destroy his internal organs, and the only humane option was to end his suffering. But Bentley was family, and Colin had already faced too much loss growing up in the dangerous border region of McAllen-Reynosa.

A rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?” That question changed everything. Colin created a CBD golden paste for Bentley. The result wasn’t placebo—dogs don’t respond to placebo. Bentley got up, walked over, and brought Colin his ball to play. From paralyzed to playing. Ten years later, Bentley passed naturally at age twenty.

During those ten years, Colin developed specialized formulas for every age-related condition Bentley faced:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure
• Arthritis → Multi-pathway anti-inflammatory approach using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. That decade of formulation research—keeping Bentley alive—became the foundation of the RSO formula we now offer to Winnebago County.

From McAllen to Houston: Building a Company With Integrity

Colin grew up in McAllen, Texas, one of the most economically challenged and dangerous border regions. He learned the cannabis plant intimately in the traditional pre-legalization world, then transitioned to legitimate business. He became a formally trained software engineer, doing custom development for Baylor College of Medicine—one of the most prestigious medical institutions in the Texas Medical Center.

That combination—deep cannabis knowledge plus medical-grade technical precision—defines OilWell’s approach. Our company operates from Montrose, Houston (810 Richmond Avenue, Houston, TX 77006). Since 2019, we’ve generated approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and hold a Texas DSHS license. All artwork, formulations, and packaging are created in-house in Houston. We bring Houston grit, McAllen roots, and a builder’s mindset to everything we do.

Colin’s Personal Journey: PTSD, Benzo Addiction, and Peace Gummies

Colin knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to quit Xanax cold turkey—a notoriously difficult and dangerous feat—he used the cannabinoid knowledge developed keeping Bentley alive.

Our Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form to manage his insomnia and severe PTSD. This isn’t theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

For Winnebago County veterans, trauma survivors, and those trapped in prescription cycles—this personal experience makes OilWell credible in a way no corporate brand can be.

Media Recognition: Why ABC13’s Coverage Matters for Winnebago County

Between September 2019 and April 2023, ABC13 Houston (KTRK)—the ABC affiliate serving America’s fourth-largest city—featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought us out: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers.

What this means for Winnebago County residents: When you choose OilWell, you’re choosing a company that major-market media has repeatedly identified as the most credible, quotable, and accessible voice in the legal cannabis industry. This isn’t paid advertising—it’s editorial recognition that cannot be purchased, only earned.

The Seven Features: A Track Record of Transparency

1. September 2019: Texas CBD Business Boom
Our foundational quote established our philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

2. March 2021: Decriminalization & Community Building
Featured Colin helping other entrepreneurs like Jonathan Pina launch High Maintenance Edibles: “Pain comes in a lot of different forms.”

3. May 2021: Delta-8 THC Investigation
Steve Campion’s iconic exchange: “Maybe you want to get high”—radical honesty on mainstream television that became one of Colin’s most quoted moments.

4. August 2021: COVID Vaccine Giveaway
We donated 1,000 caviar pre-rolls (approximately $35,000 in product) to encourage vaccination, coordinating with the City of Houston. No political strings attached—pure community health action.

5. October 2021: Delta-8 Ban Response
When Texas DSHS classified Delta-8 as Schedule I overnight, Colin proactively removed all products and warned other operators who were unknowingly shipping narcotics. We absorbed the revenue loss to act ethically.

6. October 2022: Biden Pardon Feature
Revealed Colin’s personal marijuana conviction history: “I would love to see people not get hurt for this anymore.” This transforms every quote—it’s not theory from a privileged entrepreneur, but lived experience from someone who faced consequences.

7. April 2023: 4/20 Renaissance
Colin framed the present as opportunity: “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.”

For Winnebago County residents evaluating cannabis companies online, this media record—spanning four years, five reporters, and covering business, law, medicine, and community health—provides a verifiable credibility signal that no competitor page or self-published testimonial can match.

The Science Behind Our Formula: What Winnebago County Should Know

Research Method: How We Evaluate Evidence

Our evidence hierarchy prioritizes:

1. Human clinical evidence first
2. Systematic reviews and meta-analyses
3. NIH and institutional summaries
4. Preclinical literature when human data are sparse

This matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and terpenes rely more on reviews and preclinical work. We apply the same standards to our products that we apply to everyone else’s—no special pleading.

Institutional Baseline: What NIH Says

The National Center for Complementary and Integrative Health (NCCIH) states that the strongest cannabinoid evidence is for:

• Certain rare epilepsies (CBD)
• Chemotherapy-related nausea and vomiting (THC-containing products)
• Appetite and weight loss in HIV/AIDS

NCCIH emphasizes that the FDA has not approved the cannabis plant itself for medical use. Safety concerns include impairment, cannabis use disorder, pregnancy risks, contamination, and labeling inaccuracy.

For Winnebago County residents reading about cannabis on social media or hearing claims at local gatherings, this institutional baseline provides a reality check against marketing hype.

Cannabinoid Profiles: The Complete Breakdown

CBD (4,500mg in our sublingual formula)

• Strongest evidence: Seizure disorders (Epidiolex approval)
• Emerging evidence: Anxiety (2024 meta-analysis of 316 participants showed anxiolytic signal but limited clinical sample)
• Pain: 2024 systematic review found promising but heterogeneous evidence
• Sleep: 2023 review found literature methodologically weak
• Safety: 2023 meta-analysis found real signal for liver enzyme elevation, especially concerning for concentrated oral products and polypharmacy settings
• Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence is concentrated in specific indications, not broad wellness claims

CBG (3,000mg)

• Evidence: Mostly review-level and preclinical; human evidence sparse
• Pharmacology: Interacts with cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A signaling
• Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity (all preclinical)
• Caution: Commercially sold while evidence base remains thin
• Bottom line: Promising minor cannabinoid with limited clinical validation

Delta-8 THC (6,000mg)

• Evidence: Pharmacologically relevant and psychoactive, much less clinically characterized than delta-9
• Pharmacology: Partial CB1 agonist, less potent than delta-9 due to weaker CB1 affinity
• Public health: 2023 scoping review found evidence base dominated by animal studies, product chemistry, and use reports—not strong human trials
• Manufacturing: Commercial interest tied to greater stability and easier synthesis, raising product-byproduct concerns
• Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization

THCa (1,500mg)

• Evidence: Important chemically but low on direct human therapeutic evidence
• What it is: Acidic, non-psychoactive precursor to THC
• Research: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities—not established human outcomes
• Critical for Winnebago County: THCa converts to THC when heated. This conversion is the legal innovation that makes our product accessible to you
• Bottom line: Highly relevant precursor whose interpretation depends on route, temperature, processing, and storage

Delta-9 THC (90mg total)

• Evidence: Strongest human evidence of psychoactive cannabinoids, clearest adverse-effect burden
• Institutional support: Chemo-related nausea, HIV/AIDS appetite, some MS and pain outcomes
• Pain: 2022 systematic review found high-THC products may provide short-term pain benefit but increase dizziness, sedation, nausea, and discontinuation
• Mental health risk: 2025 systematic review found consistent unfavorable associations with psychosis/schizophrenia and cannabis use disorder at high concentrations
• Bottom line: Legitimate therapeutic relevance but carries clearest intoxication, psychiatric, and dose-related safety liabilities

CBN (750mg)

• Evidence: Weak human evidence; marketing ahead of data
• Sleep claims: 2021 narrative review screened 99 human-study abstracts, found no clinical trials using validated sleep questionnaires or polysomnography
• 2024 sleep literature: Overall cannabinoid sleep research still doesn’t match real-world use scale
• Bottom line: Cultural reputation stronger than clinical evidence—prime example of overstatement

CBC (750mg)

• Evidence: Emerging, intriguing, overwhelmingly preclinical
• Pharmacology: Distinct pharmacodynamics, pharmacokinetics, receptor behavior
• Research: Antinociceptive, antibacterial, anti-seizure areas interesting in animal models
• Safety: Over-the-counter products sold despite little efficacy or safety evidence
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active

Terpene Profiles: Beyond Aroma

Our formula includes 5% live terpenes: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. While robust human proof of cannabis-specific entourage effects remains limited, preclinical literature suggests plausible bioactivity.

For Winnebago County residents familiar with Iowa’s natural environment:

• Limonene: Citrus-bright aroma, potential antioxidant/anti-inflammatory activity
• Myrcene: Found in hops and mangoes; often discussed for relaxation (but human evidence limited)
• Caryophyllene: Pepper/spice scent; selective CB2 receptor agonist—most mechanistically interesting terpene
• Pinene: Forest-fresh aroma; preclinical neuroprotective signals but weak human confirmation
• Linalool: Lavender-like; studied for stress/mood but limited human trials
• Humulene: Earthy/woody; anti-inflammatory preclinical evidence
• Terpinolene: Piney/fruity; least clinically characterized but biologically interesting

Safety note: Limonene and linalool oxidation products can be contact allergens—relevant for topical use.

Research Limits: Five Critical Rules

1. Evidence is highly uneven—CBD and delta-9 THC support strongest claims; others require caution
2. Extract/molecule/synthetic/terpene data aren’t interchangeable—common error in cannabis writing
3. Minor cannabinoids are commercially interesting BECAUSE underexplored—claims often inflated
4. Product quality matters as much as molecule identity—labeling inaccuracies, contamination, synthesis byproducts affect real-world outcomes
5. THCa chemistry changes with storage/heating—interpretation must account for conversion dynamics

Common Overstatements (And What We Actually Know)

“CBN is a proven sleep aid” → Evidence remains weak; no validated human trials

“Myrcene makes you sleepy” → Preclinical bioactivity plausible but direct human proof limited

“Terpene entourage effects are proven” → Hypotheses influential but robust clinical proof limited

“THCa is always non-psychoactive” → True only if molecule stays acidic; heating converts to THC

“Delta-8 is safe because hemp-derived” → Psychoactive analogue with incomplete safety characterization

Our RSO Formulas: Complete Transparency for Winnebago County

RSO Sublingual Oil: The Full Formula

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Format: 30mL bottle with graduated dropper (0.1mL increments)
• Onset: 15-45 minutes
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Price: $129.99

For Winnebago County residents doing the math: At $129.99 for 16,590mg total cannabinoids, you’re paying approximately $0.0078 per milligram—significantly less than the $0.04-0.10 per milligram typical of Iowa dispensary products. This cost-effectiveness matters for patients requiring long-term maintenance dosing.

RSO Vape Cartridge: The Full Formula

• Live Terpenes: 5%+
• Format: 1-gram 510-thread cartridge
• Onset: 1-2 minutes (fastest delivery)
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Price: $49.99

For Winnebago County residents needing fast relief: The vape format is ideal for breakthrough pain, panic attacks, or acute nausea. The 1-2 minute onset is unmatched by any oral product.

When to Use Each Format in Winnebago County

Condition-Specific Guidance for Winnebago County

Chemotherapy-Related Nausea & Appetite Support

Winnebago County context: Patients traveling to MercyOne Cancer Center in Mason City or Mayo Clinic in Rochester can use our RSO as adjunctive support.

Protocol:

• Pre-chemo: 0.5-1.0mL sublingual 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)

Evidence: Delta-8 antiemetic properties [9], delta-9 THC nausea reduction [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Farming Injuries, Arthritis, Neuropathy)

Winnebago County context: Agricultural workers in Winnebago County face high rates of repetitive strain injuries, back problems, and joint degeneration. Veterans in the area also experience service-related chronic pain.

Protocol:

• Daytime: 0.3-0.5mL raw sublingual—anti-inflammatory without impairment for operating equipment
• Nighttime: 0.5-1.0mL decarboxylated—combines pain relief with CBN for sleep
• Breakthrough pain: Vape as needed

Evidence: CBD pain reduction [4], delta-9 THC analgesia [13], caryophyllene CB2 activation [24], THCa COX-2 inhibition [12]

Sleep Support in Rural Iowa

Winnebago County context: Quiet rural environments can paradoxically make insomnia more noticeable. The dark skies are beautiful, but not when you’re awake at 3 AM.

Protocol:

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN—the dosage level investigated in 2024 sleep literature
• At 1.0mL: Delivers 25mg CBN—above the 20mg threshold associated with reduced sleep disturbance

Evidence: CBN sleep studies [16][17], though literature remains methodologically weak overall

Anxiety & Stress

Winnebago County context: Rural life brings unique stressors—economic uncertainty, isolation, limited mental health resources. The nearest psychiatrist may be in Mason City or Fort Dodge.

Protocol:

• Daytime functional relief: 0.3mL raw sublingual—CBD and CBG address anxiety without psychoactive impairment for work, driving, parenting
• Nighttime: 1.0mL sublingual—full profile including CBN for sleep architecture

Evidence: CBD anxiety reduction [3], CBG pharmacology [7][8], limonene entourage effects [20]

General Titration Principle for Winnebago County Residents

Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors unique to your Winnebago County lifestyle.

Legal Status & Accessibility: Getting Our RSO to Winnebago County

Farm Bill Compliance: Why This Is Legal in Iowa

Our products comply with the 2018 Farm Bill (Agricultural Improvement Act), which legalized hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level.

Our sublingual oil: Only 90mg delta-9 THC in the entire 30mL bottle (3mg/mL)—well under the 0.3% threshold.

All cannabinoids are hemp-derived. This means our RSO is legal in Iowa and can be shipped directly to Winnebago County addresses.

The THCa Innovation: Legal Access to Potency

THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC, making it Farm Bill compliant at point of sale.

The conversion process for Winnebago County residents: Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500mg THCa into approximately 1,315mg delta-9 THC. Combined with the existing 90mg delta-9 THC, you get approximately 1,405mg total delta-9 THC—psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.

Three usage options:

1. Raw (no heat): All 1,500mg stays as THCa—completely non-psychoactive, zero impairment for daytime use in Winnebago County
2. Fully activated (home decarb): Convert THCa to delta-9 THC for full psychoactive potency
3. Partial decarb: Transfer a controlled portion to a second container, decarboxylate only what you intend to use, preserve the rest raw

Legal notice for Iowa: THCa converts to delta-9 THC when heated. Iowa law follows federal Farm Bill standards. Customers are responsible for understanding their local laws. We ship with full documentation, Certificates of Analysis, and receipts for your records.

Delivery to Winnebago County

We ship nationwide via USPS Priority Mail (2-3 business days), FedEx, or UPS Ground (3-5 business days). For Winnebago County residents, this means:

• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for Iowa’s extreme seasonal variations
• Signature-required option available for security

International shipping: We have delivered to multiple countries. Winnebago County customers with family abroad can share our products where hemp laws permit.

Proprietary SEO technology: Our PANDEM1C system (14 million locations, 300+ AI models) ensures Winnebago County residents can find us when searching in their own language and context.

Why OilWell Is Different in Winnebago County

Open-Source Formulas: If You Can’t Afford It, Make It

We publish our complete formulas publicly—every cannabinoid, every milligram amount, every percentage. If you can’t afford $129.99 for our sublingual oil or $49.99 for our vape cartridge, you can source individual cannabinoid distillates and make your own version.

This echoes Rick Simpson’s original ethos: he gave oil away free and taught people to make it. We’ve adapted that for the modern marketplace—sell a professionally manufactured, lab-tested product AND publish the recipe.

The Bentley Recipe: Our First Open-Source Formula

When Bentley was paralyzed, Colin published the CBD golden paste recipe that saved him:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (for absorption)
• CBD oil (dosage depends on pet size)

Instructions:

1. Mix turmeric and water in saucepan over low heat, stirring continuously until thick paste forms (7-10 minutes)
2. Add coconut oil and pepper, stir until thoroughly mixed
3. Cool, transfer to jar, refrigerate up to 2 weeks
4. Add CBD oil before serving

This recipe—published free years before our RSO formulas—demonstrates that open-source is foundational behavior, not marketing strategy.

Competitive Advantage: OilWell vs. Iowa Options

OilWell RSO vs. Iowa Medical Cannabis Program (MCAP)

OilWell RSO vs. Hemp CBD Products (e.g., Iowa health stores)

OilWell RSO vs. Traditional Illegal RSO

Quality Standards: What Winnebago County Should Expect

Solvent-free production: No naphtha, no isopropyl alcohol, no butane. We blend individual cannabinoid distillates in organic MCT oil.

Third-party lab testing includes:

• Cannabinoid potency (HPLC/UHPLC, ±2% accuracy)
• Terpene profile
• Pesticides (400+ compounds)
• Heavy metals (arsenic, cadmium, lead, mercury)
• Residual solvents (FDA Class 3 limits <5,000 ppm)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

COAs available on request and via our website.

How to Order: Winnebago County Access

Online Ordering

Visit OilWell Cannabis RSO Guide for complete product information and ordering.

Phone: (832) 416-2816
Email: [email protected]
Website: https://oilwellcbd.com/

For Winnebago County Residents

Shipping time to Iowa: 2-3 business days via USPS Priority Mail
Packaging: Plain, discreet, no cannabis branding
Documentation: Full COAs and receipts included for legal verification

Age requirement: 21+ for RSO products
Legal compliance: Contains less than 0.3% delta-9 THC by dry weight
FDA disclaimer: These products are not evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

Contact and Support

If you’re in Winnebago County and have questions about:

• Drug interactions with medications prescribed by Hancock County Health System
• Dosing protocols for specific conditions
• Decarboxylation instructions for activating THCa
• Shipping to rural Iowa addresses

Call us at (832) 416-2816. Colin or our team will provide the same honest education we gave ABC13—no hype, just facts.

Conclusion: Winnebago County Deserves Better

Winnebago County residents face unique challenges: rural isolation, limited specialty medical access, agricultural injury risks, and veteran health concerns. You also have unique strengths: self-reliance, community connection, and practical evaluation skills.

Our RSO formula was born from Colin keeping Bentley alive for ten years, then refined through his own battle with PTSD and benzo addiction. It was validated by seven ABC13 news features over four years. It’s backed by 29 peer-reviewed research citations. And we publish every milligram so you can make your own if you need to.

For Winnebago County, this means:

• Legal access without driving 2+ hours to a dispensary
• Cost-effectiveness at $0.008/mg for long-term use
• Precision that DIY RSO can never match
• Flexibility to use raw for daytime or activated for nighttime
• Community—you’re joining thousands of customers nationwide who chose evidence over hype

Rick Simpson gave his oil away for free because he believed medicine should be accessible. We can’t give it away, but we can give you everything else: the formula, the science, the truth, and the best possible version so you can give it a fair shot and decide if it’s right for you.

Order today: OilWell Cannabis RSO
Call now: (832) 416-2816
Follow us: @oilwellcbd on Instagram

Complete Reference List

Rick Simpson References

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.
RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005. Distributed via phoenixtears.ca and online platforms.
RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca. Multiple dates. Accessed March 2026.
RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444. PMID: 22555283.
RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203. PMID: 16804518.
RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024. Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq

General Knowledge References

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know
2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.
3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.
4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.
5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.
6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.
7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.
8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.
9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.
10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.
11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.
12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.
13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.
14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.
15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.
16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.
17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.
18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.
19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.
20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.
21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.
22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.
23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.
24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.
25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.
26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.
27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.
28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.
29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

Final Note for Winnebago County: Every claim in this document is backed by peer-reviewed research or verifiable media coverage. Every formula is published openly. Every question has an honest answer—even when that answer is “we need more research.” That’s the OilWell promise to Iowa: the same integrity we’d want for our own families in Houston, now available for yours in Winnebago County.

Order RSO for Winnebago County Delivery